Clinical Trial Update: Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating low-dose radiotherapy combined with sintilimab and chemotherapy as neoadjuvant therapy for Stage I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Anhui Provincial Cancer Hospital | Conditions: NSCLC, Neoadjuvant Immunotherapy | Phase 2 | Status: RECRUITING